Kinyanjui SM
25 results
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K
J Infect Dis, (2004). 190:1527-33
The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K
J Immunol Methods, (2004). 288:9-18
Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens.Kinyanjui SM, Bull P, Newbold CI, Marsh K
J Infect Dis, (2003). 187:667-74
The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.Kinyanjui SM, Mberu EK, Winstanley PA, Jacobus DP, Watkins WM
Am J Trop Med Hyg, (1999). 60:943-7
Antimalarial activity in crude extracts of Malawian medicinal plants.Connelly MP, Fabiano E, Patel IH, Kinyanjui SM, Mberu EK, Watkins WM
Ann Trop Med Parasitol, (1996). 90:597-602